Scholarlink

<p>Medullary thyroid cancer (MTC) is a rare neuroendocrine malignancy arising from parafollicular C cells. Diagnosis is based on cytologic and histologic features, supported by biochemical testing for calcitonin and carcinoembryonic antigen, <i>RET</i> germline testing, and appropriate imaging. This educational review, developed by the Society of Surgical Oncology’s Endocrine and Head and Neck Disease Site Working Group, provides an updated overview of the diagnosis and management of MTC, emphasizing evolving surgical principles and the integration of targeted therapies. Ongoing multidisciplinary collaboration and participation in clinical trials remain essential to further refine prognostic tools, optimize treatment sequencing, and improve patient outcomes in MTC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Management of Medullary Thyroid Cancer: A Review

  • 期刊论文

  • 发表日期：

    2026年5月11日

查看全文
  • Amblessed E. Onuma,
  • Saba Kurtom,
  • Lauren N. Krumeich,
  • Sarah B. Fisher,
  • Paxton Dickson,
  • Yinin Hu

摘要

Medullary thyroid cancer (MTC) is a rare neuroendocrine malignancy arising from parafollicular C cells. Diagnosis is based on cytologic and histologic features, supported by biochemical testing for calcitonin and carcinoembryonic antigen, RET germline testing, and appropriate imaging. This educational review, developed by the Society of Surgical Oncology’s Endocrine and Head and Neck Disease Site Working Group, provides an updated overview of the diagnosis and management of MTC, emphasizing evolving surgical principles and the integration of targeted therapies. Ongoing multidisciplinary collaboration and participation in clinical trials remain essential to further refine prognostic tools, optimize treatment sequencing, and improve patient outcomes in MTC.